These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1359 related items for PubMed ID: 8521757
1. Practical recommendations and new therapies for Wilson's disease. Brewer GJ. Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757 [Abstract] [Full Text] [Related]
7. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F. Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [Abstract] [Full Text] [Related]
8. Current Drug Managements of Wilson's Disease: From West to East. Li WJ, Chen C, You ZF, Yang RM, Wang XP. Curr Neuropharmacol; 2016 Dec; 14(4):322-5. PubMed ID: 26639459 [Abstract] [Full Text] [Related]
9. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases. Brewer GJ. Metallomics; 2009 Dec; 1(3):199-206. PubMed ID: 21305118 [Abstract] [Full Text] [Related]
10. Clinical considerations for an effective medical therapy in Wilson's disease. Weiss KH, Stremmel W. Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532 [Abstract] [Full Text] [Related]
11. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Brewer GJ, Askari F, Dick RB, Sitterly J, Fink JK, Carlson M, Kluin KJ, Lorincz MT. Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438 [Abstract] [Full Text] [Related]
12. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Merle U, Schaefer M, Ferenci P, Stremmel W. Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660 [Abstract] [Full Text] [Related]
13. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease. Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A. J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794 [Abstract] [Full Text] [Related]
14. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. J Lab Clin Med; 1998 Oct; 132(4):264-78. PubMed ID: 9794697 [Abstract] [Full Text] [Related]
15. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Hoogenraad TU. Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879 [Abstract] [Full Text] [Related]
16. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy]. Serra B, Primo J, García M, Amorós I, Aragó M, Merino C. Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609 [Abstract] [Full Text] [Related]
17. [Pathogenesis and treatment of Wilson's disease]. Nagy J, Vincze Z, Folhoffer A, Horváth A, Csák T, Zelkó R. Acta Pharm Hung; 2003 May; 73(4):237-41. PubMed ID: 15279036 [Abstract] [Full Text] [Related]
18. Diagnosis and treatment of Wilson's disease. Subramanian I, Vanek ZF, Bronstein JM. Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251 [Abstract] [Full Text] [Related]